Skip to main content
. 2020 Aug 10;15(2):416–424. doi: 10.1007/s12105-020-01210-7

Table 1.

Clinicopathological features of patients with head and neck AdCC

Characteristics n (%)
Sex
 Male 40 (46.0)
 Female 47 (54.0)
Age
  ≤ 50 years 42 (48.3)
  > 50 years 45 (51.7)
 Mean ± standard deviation 51.5 ± 14.8
Primary site
 Parotid gland 27 (31.0)
 Submandibular gland 15 (17.2)
 Palate 19 (21.8)
 Tongue 5 (5.7)
 Nasal cavity/paranasal sinus/nasopharynx 10 (11.4)
 Lacrimal gland 4 (4.6)
 Other sites 7 (8.0)
Tumor size (T)
 T1 23 (26.4)
 T2 21 (24.1)
 T3 14 (16.1)
 T4 29 (33.3)
Lymph node metastasis (N)
 N0 75 (86.2)
 N1 7 (8.0)
 N2 3 (3.4)
 N3 2 (2.3)
Distant metastasis (M)
 M0 73 (83.9)
 M1 14 (16.1)
TNM stage
 I 21 (24.1)
 II 17 (19.5)
 III 10 (11.5)
 IV 39 (44.8)
Histopathological pattern
 Tubular 31 (35.6)
 Cribriform 36 (41.4)
 Solid 20 (23.0)
Perineural invasion
 Absent 33 (37.9)
 Present 54 (62.1)
Surgical margins
 Negative 50 (57.5)
 Positive 37 (42.5)
Treatment
 Surgery 16 (18.4)
 Surgery + RT 38 (43.7)
 Surgery + ChT 2 (2.3)
 Surgery + RT + ChT 26 (29.9)
 RT + ChT 4 (4.6)
 ChT 1 (1.1)
Recurrence
 No 57 (65.5)
 Yes 30 (34.5)
Survival statusa
 Remission 40 (49.4)
 Disease in progression 12 (14.8)
 Death caused by tumor 29 (35.8)
 Total 87 (100.0)

TNM tumor-node-metastasis, RT radiotherapy, ChT chemotherapy

aSix cases had no information regarding survival status